141 related articles for article (PubMed ID: 21905083)
41. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
42. [Epstein-Barr virus in Hodgkin's disease: the example of central Tunisia].
Korbi S; Trimeche M; Sriha B; Yacoubi MT; Hmissa S; Mokni M; Delvenne P; Boniver J; Rammeh S
Ann Pathol; 2002 Apr; 22(2):96-101. PubMed ID: 12124490
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
44. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
45. Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?
Cavalcante P; Barzago C; Baggi F; Antozzi C; Maggi L; Mantegazza R; Bernasconi P
Ann N Y Acad Sci; 2018 Feb; 1413(1):11-24. PubMed ID: 29363775
[TBL] [Abstract][Full Text] [Related]
46. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma--another point of view.
Preciado MV
Breast Cancer Res; 2003; 5(4):E6; author reply E7. PubMed ID: 12817996
[No Abstract] [Full Text] [Related]
47. Detection of human parvovirus B19 infection in the thymus of patients with thymic hyperplasia-associated myasthenia gravis.
Gong L; Li Y; Li X; Tu Q; Mou X; Wang S; Wan Y; Lu Q; Wang J; Zhang W; Zhu S; Han X; Yao L; Zhang J; Huang G; Zhang W
Clin Microbiol Infect; 2019 Jan; 25(1):109.e7-109.e12. PubMed ID: 29649594
[TBL] [Abstract][Full Text] [Related]
48. Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis.
Cavalcante P; Maggi L; Colleoni L; Caldara R; Motta T; Giardina C; Antozzi C; Berrih-Aknin S; Bernasconi P; Mantegazza R
Autoimmune Dis; 2011; 2011():213092. PubMed ID: 21961056
[TBL] [Abstract][Full Text] [Related]
49. [Ultrastructural study of the thymus in patients with myasthenia gravis].
Li SX; Hu ZL; Zeng LQ
Zhonghua Nei Ke Za Zhi; 1993 May; 32(5):310-2. PubMed ID: 8269758
[TBL] [Abstract][Full Text] [Related]
50. Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis.
Kirchner T; Schalke B; Melms A; von Kügelgen T; Müller-Hermelink HK
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):237-57. PubMed ID: 2879380
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?
Cavalcante P; Marcuzzo S; Franzi S; Galbardi B; Maggi L; Motta T; Ghislandi R; Buzzi A; Spinelli L; Novellino L; Baggi F; Antozzi C; Conforti F; De Pas TM; Barberis M; Bernasconi P; Mantegazza R
Oncotarget; 2017 Nov; 8(56):95432-95449. PubMed ID: 29221139
[TBL] [Abstract][Full Text] [Related]
52. Absence of the Epstein-Barr virus genome in the normal thymus, thymic epithelial tumors, thymic lymphoid hyperplasia in a European population.
Borisch B; Kirchner T; Marx A; Müller-Hermelink HK
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(6):359-65. PubMed ID: 1981404
[TBL] [Abstract][Full Text] [Related]
53. The thymus and the pathogenesis of myasthenia gravis.
Levinson AI; Wheatley LM
Clin Immunol Immunopathol; 1996 Jan; 78(1):1-5. PubMed ID: 8599878
[No Abstract] [Full Text] [Related]
54. Human foamy virus genome in the thymus of myasthenia gravis patients.
Liu WT; Kao KP; Liu YC; Chang KS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 Aug; 29(3):162-5. PubMed ID: 10592798
[TBL] [Abstract][Full Text] [Related]
55. [Changes in the non-neoplastic thymus in myasthenia gravis].
Havlicek J
Cesk Patol; 1983 Aug; 19(3):178-84. PubMed ID: 6627468
[TBL] [Abstract][Full Text] [Related]
56. Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis.
Roxanis I; Micklem K; McConville J; Newsom-Davis J; Willcox N
J Neuroimmunol; 2002 Apr; 125(1-2):185-97. PubMed ID: 11960656
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus--positive undifferentiated thymic carcinoma in a 12-year-old white girl.
Stéphan JL; Galambrun C; Boucheron S; Varlet F; Delabesse E; MacIntyre E
J Pediatr Hematol Oncol; 2000; 22(2):162-6. PubMed ID: 10779032
[TBL] [Abstract][Full Text] [Related]
58. AMP-deaminase from thymus of patients with myasthenia gravis.
Rybakowska I; Szydłowska M; Szrok S; Bakuła S; Kaletha K
Nucleosides Nucleotides Nucleic Acids; 2015; 34(3):229-34. PubMed ID: 25710358
[TBL] [Abstract][Full Text] [Related]
59. Thymic extracellular matrix in myasthenia gravis. II. Immunohistochemical evidence for increased type I collagen degradation.
Savino W; Emonard H; Grimaud JA
J Neuroimmunol; 1988 Jun; 18(3):223-30. PubMed ID: 3366881
[TBL] [Abstract][Full Text] [Related]
60. Thymic hyperplasia in myasthenia gravis: immunohistological abnormalities and responsiveness to recombinant IL2.
Cohen-Kaminsky S; Berrih-Aknin S; Safar D
Adv Exp Med Biol; 1988; 237():375-81. PubMed ID: 3075859
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
